CURRENT PROJECTS

• Setting payment-levels within the commercial arrangements for new antibiotics

• Elective surgery waiting time prioritisation to improve population health gains and reduce health inequalities

• Economic analysis to support NHS decisions relating to the use of the Galleri test in a screening population

• Estimating opportunity costs for the NHS, public health and social care

• Assessing the value of novel antimicrobials under new payment models

COMPLETED PROJECTS

• Estimating the Shares of the Value of Branded Pharmaceuticals Accruing to Manufacturers and to the NHS

• Rapid review of COVID-19 UK policy focused decision models

• Burden and effectiveness of interventions to address overprescribing

• Estimating the shares of the value of branded pharmaceuticals accruing to manufacturers and to the NHS

• Mental health care contract design

• Prevalence and economic burden of medication errors in the NHS in England

• De-linking reimbursement of antimicrobials from volumes sold: assessing alternative arrangements and implications for NICE appraisal

• ACE: Economic evaluation of the proactive lung cluster

CURRENT PROJECTS

• Evidence of health inequalities by ethnic group for use alongside economic evaluation

• Going beyond health opportunity costs: exploring the potential effects of publicly funded Adult Social Care on individual net production

• Methods to better identify when preference-based outcome measures may undervalue benefits

• Methods for valuing the benefits of care interventions for economic evaluation

• Economic evaluation and modelling methods in the context of bottlenecks in the diagnosis and treatment of cancer

• Evaluation of different models of stratified breast screening policies in terms of public health impact and demands on resources

COMPLETED PROJECTS

• Estimating the relationship between EQ-5D-5L and EQ-5D-3L

• Allocative efficiency

CURRENT PROJECTS

• Understanding public and expert views around the normative decisions made to ‘value’ health-related quality of life in children and young people: a mixed-methods study

• A literature review of methods used to value benefits in cost-effectiveness analyses of interventions for patients at the end of life 

• Assessing the content validity of child and adolescent-specific preference-based measures with potential to inform UK policy

• Assessing the psychometric properties of EQ-5D-5L in people living with dementia

COMPLETED PROJECTS

• A discrete choice experiment to elicit general population stated preferences around the determinants of the choice to make clinical negligence claims against the NHS

• Scoping, assessing feasibility, preliminary research and prioritising projects for the outcome measurement and valuation EEPRU theme

• Validating a new measure of wider quality of life (EQ-HWB (Health and Wellbeing) and exploring the differences and relationships with existing health outcome (EQ-5D-5L), social care (ASCOT) and capability (ICECAP) measures

• Validation of the EQ-5D-5L valuation set

• Recovering quality of life (ReQol)